Therapy for Scabies With Two Differently Concentrated Permethrin Creams

Summary

The multi-center, prospective, randomized, double-blind phase III clinical trial will primarily investigate the efficacy and safety of treatment of scabies with Permethrin Cream 5% (approved drug InfectoScab 5% Cream) in direct comparison with Permethrin Cream 10%. The trial participants will be randomly assigned and blinded to either Permethrin Cream 5% or Permethrin Cream 10%.

Timeline

Start

2024-05

Primary completion

2027-07

Completion

2028-12

Drugs

Indications